Glaucoma Update 2026: Management of Routine and Complex Glaucoma Cases

Click here to register for the livestream!

We will discuss latest advances in the management of glaucoma and evidence for emerging therapies and screening modalities. Both point/counter-point and didactic formats will be utilized to illustrate current trends in the management of complex and routine glaucoma patients, taking into account novel techniques as well as interdisciplinary glaucoma management.

1. Integrate advanced surgical techniques into the management of complex glaucoma cases.
2. Assess and manage complex clinical glaucoma presentations using current guidelines and best practices.
3. Evaluate new and emerging glaucoma devices and treatment modalities for appropriate clinical integration.

AMA PRA Statement
Wills Eye Hospital designates this Live Activity for a maximum of 3.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Elizabeth Dale, MD
Ophthalmic Partners PC

Faculty

Speakers Bureau-Sight Sciences|Speakers Bureau-Thea Pharmacueticals

Jason Flamendorf, MD
Society Hill Ophthalmic Associates

Faculty

Anfei Li, MD, PhD
Ophthalmic Partners

Faculty

Nothing to disclose

Lindsay Machen, MD
Wills Eye Hospital

Faculty

Nothing to disclose

Jonathan S. Myers, MD
Wills Eye Hospital

Faculty

Stocks or stock options, excluding diversified mutual funds-Avisi|Stocks or stock options, excluding diversified mutual funds-Olleyes|Grant or research support-AbbVie (Relationship has ended)|Grant or research support-Glaukos Corporation|Grant or research support-Nicox (Relationship has ended)|Grant or research support-Santen Pharmaceuticals (Relationship has ended)|Grant or research support-Guardian (Relationship has ended)|Grant or research support-Laboratories Thea Inc|Grant or research support-Ocular Therapeutix (Relationship has ended)|Grant or research support-Elios (Relationship has ended)|Grant or research support-PLU Ophthalmic (Relationship has ended)|Consulting Fee-Thea Labs|Honoraria-Glaukos Corporation

Rachel Niknam, MD
Kay and Tabas ophthalmology

Faculty

Reza Razeghinejad, MD
WEH

Faculty

Grant or research support-Olleyes

Jesse Richman, MD
Kremer Eye Center

Faculty

Consulting Fee-Alcon|Royalties or Patent Beneficiary-Visionology|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Visionology (Relationship has ended)|Paid consultant-Allergan (Relationship has ended)

Tina Xia, MD
Wills Eye

Faculty

Dilru C Amarasekera, MD
Wills Eye Hospital

Faculty, Peer Reviewer, Planner

Paid consultant-Microt (Relationship has ended)

Michael Pro, MD
Ophthalmic Partners of PA

Faculty, Planner

Consulting Fee-Alcon (Relationship has ended)|Honoraria-Glaukos Corporation|Consulting Fee-New World Medical

Saturday, February 7, 2026